Core Viewpoint - The patent dispute between leading XR companies VITURE and XREAL has garnered market attention, with a temporary injunction issued against VITURE Pro in Germany, which the company is appealing, asserting that its business remains unaffected [1][10]. Group 1: Patent Dispute Details - The patent in question is European patent EP3754409B1 held by XREAL, which pertains to the Birdbath optical system for AR devices [1]. - VITURE claims that its VITURE Pro was launched in Germany before the patent was authorized and that the patent is currently within a 9-month opposition period [8][10]. - XREAL's lawsuit in Germany is strategically timed due to the country's quick infringement litigation process, contrasting with the lengthy patent invalidation process [8]. Group 2: Market Impact and Company Performance - Despite the legal challenges, VITURE's market share in the U.S. reached 28.1% in Q3 2025, with an annual growth rate exceeding 100% [8][12]. - VITURE emphasizes that its products are still available for sale across Europe, with no listings removed, and it continues to lead in several European markets [13][15]. - The company has expressed confidence in its legal position, viewing the situation as a procedural issue rather than a substantive infringement [15].
VITURE回应XREAL纠纷:已上诉且业务未受实质影响
Huan Qiu Wang·2025-12-24 09:31